Clinical characteristics and outcomes among patients with COVID-19

References

1. 1.↵
   1. Wu Z,
   2. McGoogan JM.

   Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72 314 cases from the Chinese Center for Disease Control and Prevention. JAMA 2020; 323: 1239–1242.

   OpenUrlCrossRefPubMed
2. 2.↵
   World Health Organization. Coronavirus disease (COVID-19) dashboard. [Updated 2020; accessed 2022 May 26]. Available from: https://covid19.who.int/
3. 3.↵
   1. Wang D,
   2. Hu B,
   3. Hu C,
   4. Zhu F,
   5. Liu X,
   6. Zhang J, et al.

   Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus–infected pneumonia in Wuhan, China. JAMA 2020; 323: 1061–1069.

   OpenUrlCrossRefPubMed
4. 4.↵
   1. Popov GT,
   2. Baymakova M,
   3. Vaseva V,
   4. Kundurzhiev T,
   5. Mutafchiyski V.

   Clinical characteristics of hospitalized patients with COVID-19 in Sofia, Bulgaria. Vector Borne Zoonotic Dis 2020; 20: 910–915.

   OpenUrl
5. 5.
   1. Guan WJ,
   2. Ni ZY,
   3. Hu Y,
   4. Liang WH,
   5. Ou CQ,
   6. He JX, et al.

   Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med 2020; 382: 1708–1720.

   OpenUrlCrossRefPubMed
6. 6.↵
   1. Docherty AB,
   2. Harrison EM,
   3. Green CA,
   4. Hardwick HE,
   5. Pius R,
   6. Norman L. et al.

   Features of 20 133 UK patients in hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: prospective observational cohort study. BMJ 2020; 369: m1985.

   OpenUrlAbstract/FREE Full Text
7. 7.↵
   1. Huang C,
   2. Wang Y,
   3. Li X,
   4. Ren L,
   5. Zhao J,
   6. Hu Y, et al.

   Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. The lancet. 2020; 395: 497–506.

   OpenUrlCrossRefPubMed
8. 8.↵
   1. Chen N,
   2. Zhou M,
   3. Dong X,
   4. Qu J,
   5. Gong F,
   6. Han Y, et al.

   Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. The Lancet 2020; 395: 507–513.

   OpenUrlCrossRef
9. 9.↵
   1. Hu Y,
   2. Sun J,
   3. Dai Z,
   4. Deng H,
   5. Li X,
   6. Huang Q, et al.

   Prevalence and severity of corona virus disease 2019 (COVID-19): A systematic review and meta-analysis. Journal of Clinical Virology 2020; 127: 104371.

   OpenUrlCrossRefPubMed
10. 10.↵
    1. Yang J,
    2. Zheng Y,
    3. Gou X,
    4. Pu K,
    5. Chen Z,
    6. Guo Q, et al.

    Prevalence of comorbidities and its effects in patients infected with SARS-CoV-2: a systematic review and meta-analysis. Int J Infect Dis 2020; 94: 91–95.

    OpenUrlCrossRefPubMed
11. 11.↵
    1. Seiglie J,
    2. Platt J,
    3. Cromer SJ,
    4. Bunda B,
    5. Foulkes AS,
    6. Bassett IV, et al.

    Diabetes as a risk factor for poor early outcomes in patients hospitalized with COVID-19. Diabetes Care 2020; 43: 2938–2944.

    OpenUrlAbstract/FREE Full Text
12. 12.↵
    1. Ruan Q,
    2. Yang K,
    3. Wang W,
    4. Jiang L,
    5. Song J.

    Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China. Intensive Care Med 2020; 46: 846–848.

    OpenUrlCrossRefPubMed
13. 13.↵
    1. Fang Y,
    2. Zhang H,
    3. Xie J,
    4. Lin M,
    5. Ying L,
    6. Pang P, et al.

    Sensitivity of chest CT for COVID-19: comparison to RT-PCR. Radiology 2020; 296: E115–E117.

    OpenUrlCrossRefPubMed
14. 14.↵
    1. Nouh FA,
    2. Othman H,
    3. Gwarsha E K,
    4. Elbadry AA,
    5. Alabdali A,
    6. Barassi IF, et al.

    Apparent Association of Insulin With Interleukin-6 (IL-6) in Severe COVID-19 Patients Having Chronic Disease Comorbidities. Cureus 2022; 14: e23790.

    OpenUrl
15. 15.↵
    1. Acheampong DO,
    2. Barffour IK,
    3. Boye A,
    4. Aninagyei E,
    5. Ocansey S,
    6. Morna MT.

    Male predisposition to severe COVID-19: Review of evidence and potential therapeutic prospects. Biomed Pharmacother 2020:110748.
16. 16.↵
    1. Wu C,
    2. Chen X,
    3. Cai Y,
    4. Xia J,
    5. Zhou X,
    6. Xu S, et al.

    Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China. JAMA Intern Med 2020; 180: 934–943.

    OpenUrlPubMed
17. 17.↵
    1. Drager LF,
    2. Pio-Abreu A,
    3. Lopes RD,
    4. Bortolotto LA.

    Is hypertension a real risk factor for poor prognosis in the COVID-19 pandemic? Curr Hypertens Rep. 2020; 22: 1–6.

    OpenUrl
18. 18.↵
    1. Khan A,
    2. Althunayyan S,
    3. Alsofayan Y,
    4. Alotaibi R,
    5. Mubarak A,
    6. Arafat M, et al.

    Risk factors associated with worse outcomes in COVID-19: a retrospective study in Saudi Arabia. East.Mediterr Health J 2020; 26: 1371–1380.

    OpenUrl
19. 19.↵
    1. Li X,
    2. Wang L,
    3. Yan S,
    4. Yang F,
    5. Xiang L,
    6. Zhu J, et al.

    Clinical characteristics of 25 death cases with COVID-19: a retrospective review of medical records in a single medical center, Wuhan, China. Int J Infect Dis 2020; 94: 128–32.

    OpenUrlCrossRefPubMed
20. 20.↵
    1. Gold MS,
    2. Sehayek D,
    3. Gabrielli S,
    4. Zhang X,
    5. McCusker C,
    6. Ben-Shoshan M.

    COVID-19 and comorbidities: a systematic review and meta-analysis. Postgrad Med 2020; 132: 749–755.

    OpenUrl